Menu
My ERA Join ERA
Suggestions
My Era Join ERA
Home | ERA Guidance

ERA Guidance

About ERA Guidance

ERA actively engages in collaborations with other professional societies to develop comprehensive clinical guidelines. By combining expertise across disciplines, these partnerships ensure that recommendations are evidence-based, practical, and aligned with the latest advances in nephrology. Such joint efforts not only harmonize standards of care internationally but also foster innovation and improve patient outcomes.

Collaborate with ERA

Societies interested in co-developing guidelines with ERA are warmly encouraged to reach out and explore collaborative opportunities.

For more details or enquiries, please contact cooperation@era-online.org.

KDIGO and ERA agreement

KDIGO Logo The renewed agreement between KDIGO and ERA, signed during the 2025 ERA Congress in Vienna, reinforces the strong and ongoing collaboration between the two organizations.
This partnership continues to focus on shared goals in education, the development of clinical guidelines, and their broad dissemination. It encompasses joint initiatives such as the creation of educational programs, translation of key materials, and the publication of ERA commentaries on KDIGO guidelines in ERA journals.
The overarching aim is to enhance the implementation of clinical guidelines across the nephrology community and to promote deeper scientific collaboration between the societies.

Collaboration on guidelines

Below is a list of ERA collaborative efforts.

2026 ESE-ERA Guideline

2026 ESE-ERA Guideline

2026 European Society for Endocrinology (ESE) and European Renal Association (ERA) Guideline on Hyponatraemia. Chaired by Mark Sherlock (ESE) and Ewout Hoorn (ERA).

2026 ESC-ERA Guidelines

2026 ESC-ERA Guidelines

2026 ESC Guidelines for the management of cardiovascular disease in chronic kidney disease [working title], developed in collaboration with the European Renal Association (ERA). Chaired by Kevin Damman and Will Herrington.

2023 ERA-ESH Guidelines

2023 ERA-ESH Guidelines

A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial Hypertension.

 

READ THE GUIDELINES

Clinical Guidance from the ERA Journals

Discover articles from each of the ERA Journals – Nephrology Dialysis Transplantation (NDT) and Clinical Kidney Journal (CKJ) – providing guidance for nephrology practitioners in a clinical setting.

DISCOVER MORE

ERA Body Commentaries & Clinical Practice

Developed by the ERA Bodies, these documents provide expert, practice‑oriented insights into key topics in kidney care.

Cardiovascular and Hypertension

  1. Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH)

Chronic Kidney Disease (CKD)

  1. KDIGO 2026 clinical practice guideline for Anemia in Chronic Kidney Disease (CKD): a commentary from the European Renal Best Practice (ERBP)
  2. Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a clinical practice document by the European Renal Best Practice board of the European Renal Association
  3. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease in Children and Adults: a commentary from the European Renal Best Practice (ERBP)

Genetic Kidney disease

  1. KDIGO 2025 ADPKD guideline: a commentary on diagnosis and management of hepatopancreatic manifestations by the ERA Working Group Genes & Kidney
  2. Diagnosis, management and treatment of the Alport syndrome – 2024 guideline on behalf of ERKNet, ERA and ESPN
  3. Chronic Kidney Disease of unexplained cause (CKDx): a consensus statement by the Genes & Kidney Working Group of the ERA
  4. Inherited kidney disease and CAKUT are common causes of kidney failure requiring kidney replacement therapy: an ERA Registry study

Glomerular & Immunonephroplogy

  1. Disease-modifying anti-nephropathic drugs (DMANDs)—a definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)

Diabetic Kidney Disease (DKD)

  1. Mineralocorticoid receptor antagonist use in chronic kidney disease with type 2 diabetes: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA)
  2. SGLT2i for evidence-based cardiorenal protection in diabetic and non-diabetic chronic kidney disease: a comprehensive review by EURECA-m and ERBP working groups of ERA

Transplantation

  1. Management of Antithrombotic Therapies in Kidney Transplantation Candidates and Recipients: An ERBP (European Renal Best Practice) Clinical Practice Document by the Descartes Working Group of the European Renal Association (ERA) and the Ekita Committee of the European Society of Organ Transplantation (ESOT)